An observational study in Patellofemoral Pain Syndrome, sponsored by Ahram Canadian University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2024-12-17.
Sponsored by Ahram Canadian University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 26 studies in Patellofemoral Pain Syndrome with a site in Egypt — 9 open to participants now, 11 under way, none of them phase 3. Patellofemoral Pain Syndrome · Egypt.
Among the 26 studies in Patellofemoral Pain Syndrome with a site in Egypt, this one is one of 5 that started in 2024, is one of 8 observational ones, reaches primary completion later than 1 of the 10 other live ones, and was the 14th registered.
297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 73 are open to participants now.
Browse Patellofemoral Pain Syndrome studies →9 of the 26 studies in Patellofemoral Pain Syndrome with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18–30
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 18–35
Cairo University · Sites in Egypt
Ages 18–40
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 44 Patellofemoral Pain Syndrome studies recruiting now, 3 (7%) set no upper age limit and 40 (91%) stop at 75 or younger; 6 take children under 18; 12 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
26 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 5 started in 2024.
This study's planned enrollment of 37 is below the median of 43 across 48 observational studies indexed under Patellofemoral Pain Syndrome.
Median enrollment 49 across the 18 interventional studies, 41 across the 8 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 26 has an industry lead sponsor. The 4 most frequent:
Ahram Canadian University is the lead sponsor of 71 studies on the registry; 41 are open to participants now.
Ahram Canadian University has 4 studies filed under Patellofemoral Pain Syndrome — fewer than ten, so there is no comparison to draw.
1 of the studies in Patellofemoral Pain Syndrome with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07465380Ahram Canadian UniversityStabilization vs Corrective Exercise in PFP | 2027-01 |
Add it to your calendar (.ics) → With an account.
Among the 26 studies in Patellofemoral Pain Syndrome with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patellofemoral pain syndrome (PFPS) is one of the most typical causes of anterior knee pain in adolescents and young adults under the age of 50.It is believed that imbalanced action between quadriceps components, is the most contributing cause of PFPS.Investigating exercises that increase VMO muscle activation and enhance the ratio between VMO and VL have been a standardized target in literature.
Participants will have the assessed limb ready by shaving the hair on thigh and using alcohol swabs to clean the area from any residues.
For the VMO, a surface EMG electrode will be placed 4 cm superior and 4 cm medial to the supromedial boarder of patella at approximately 55 degrees to the long axis of the femur. As for the VL, the electrode will be placed 10 cm superior and 6-8 cm lateral to the superior lateral boarder of the patella and orientated 15 degrees to the vertical. All electrodes are self-adhesive (Figure 8) and will be connected to EMG sensors that will be attached and secured by double-sided tape.Each participant will perform three consecutive squats with 5 seconds interval break between each repetition. The squat depth will be kept at 50 degrees knee flexion. Mean muscle activity from three squat repetitions of VMO and VL is recorded and VMO:VL ratio is calculated. Afterward, each participant will perform the TFL stretch and repeat the three squats again.
patients referred from orthopedic surgeon with diagnosis of PFPS
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
To stretch Tensor fascia lata muscle,each participant starts with side lying position with the tested limb upmost. The lower limb (non-tested) is kept in hip and knee flexion to ensure stability. The tested limb is then taken into hip extension and adduction with knee extended. The exercise is held for 60 seconds and repeated 5 times with 10 seconds break intervals.
VMO muscle activity
VMO muscle activity during squat is assessed by EMG device
Time frame: During the procedure
VMO to VL ratio
Ratio between VMO and VL activity during squat
Time frame: Immediately after the procedure
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2024 (actual). Primary completion is estimated for Dec 2024, 3 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Patellofemoral Pain Syndrome →
Ahram Canadian University